Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - thickness
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - size
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
10f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0133
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - back
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVPWd
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.922
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - shape
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - whole body
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.926
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Trunk curl
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.816
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of thoracic vertebrae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of thoracic vertebrae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.472
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Eosinophils
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0223
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight before experiment
|
HET
|
4f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight before experiment
|
HET
|
6f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Pre-cue freezing total
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.121
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Radius
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Radius
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total food intake
|
HET
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0163
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total food intake
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.283
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fibula
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fibula
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Context freezing total
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0436
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Eosinophil differential count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000130
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Percentage center time
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.661
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Shape of vertebrae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Shape of vertebrae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 6kHz-evoked ABR Threshold
|
HET
|
9f:3m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0261
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.580
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Brachydactyly
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Brachydactyly
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration cue-2
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body length
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.105
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body length
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.379
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - presence
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
0.619
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower teeth appearance
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Scapulae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Scapulae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Vocalization
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of Rears
|
HET
|
40f:24m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - back paws
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - shape
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD62L+ T-Regs
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.140
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery distance travelled
|
HET
|
10f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.792
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.630
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Zygomatic bone
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Zygomatic bone
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration habituation
|
HET
|
20f:12m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.678
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Echo / HR
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00231
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B1B Cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0934
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK KLRG1+ cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.113
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Shape of ribs
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Shape of ribs
|
HET
|
5f:m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Percentage center movement time
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0684
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.190
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail elevation
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Contact righting
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - number
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - ear
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Hematocrit
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.359
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength normalised against body weight
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000257
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN NKT cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.770
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - head
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Body weight
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.359
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - abdomen
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1_S
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI3
|
HET
|
9f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0922
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.377
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.834
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration habituation-2
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.488
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 30kHz-evoked ABR Threshold
|
HET
|
9f:3m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0191
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0371
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.137
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - shape
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tremor
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.598
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Viability Primary Screen / Viability Outcome
|
HOM
|
f:m
|
Supplied as data
|
0.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.253
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - morphology
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Large Unstained Cell (LUC) count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.675
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total water intake
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.0399
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total water intake
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.345
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ CD4+ NKT cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.843
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Lymphocyte cell count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0584
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head morphology
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.305
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper teeth appearance
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
71f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
88f:132m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Body Weight
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center distance travelled
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0204
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 18kHz-evoked ABR Threshold
|
HET
|
9f:3m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0390
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Triglycerides
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.622
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration pre-cue
|
HET
|
20f:12m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Clavicle
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Clavicle
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT DN KLRG1+ cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.896
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Weight / Body weight curve
|
HET
|
79f:46m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-1
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.619
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / Body weight
|
HET
|
9f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Platelet count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000346
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Activity (body position)
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Monocytes
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.182
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - size
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration habituation-1
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.832
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative food intake
|
HET
|
88f:132m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative food intake
|
HET
|
132f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Digit integrity
|
HET
|
4f:5m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Digit integrity
|
HET
|
5f:m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - snout
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0492
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN T cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - position
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0112
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.151
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / T Cells (panel B)
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.481
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD44+ T-Regs
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.120
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of cervical vertebrae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of cervical vertebrae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Follicular B Cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.765
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Latency to center entry
|
HET
|
10f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0194
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Jump
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - size
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fusion of vertebrae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fusion of vertebrae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVIDd
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.840
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Tibia
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Tibia
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - morphology
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - abdomen
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - length
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.569
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Eosinophil cell count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00126
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vocalization
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / cDCs
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.739
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement mean
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00123
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 NKT cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Hemoglobin
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.182
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative water intake
|
HET
|
132f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative water intake
|
HET
|
88f:132m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
71f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
88f:132m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Syndactylism
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Syndactylism
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena resting time
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
6.01×10-05
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Teeth presence
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head size
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength normalised against body weight
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00612
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - back
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center average speed
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.822
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK cells (panel A)
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.563
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B2B Cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.892
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - shape
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Alive
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Alive
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD24+ CD8 T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.300
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Content (excluding skull)
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.254
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Content (excluding skull)
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.347
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Neutrophil differential count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.123
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - snout
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - back
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Spleen weight
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel B
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.235
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI2
|
HET
|
9f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0429
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - S
|
HET
|
9f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.731
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
50f:30m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Type of response
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery average speed
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0234
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Processes on vertebrae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Processes on vertebrae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration cue
|
HET
|
20f:12m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Maxilla/Pre-maxilla
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Maxilla/Pre-maxilla
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Context freezing total
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0409
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Transfer arousal
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Lymphocyte differential count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000913
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.448
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Mouth morphology
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Neutrophils
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.393
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Monocyte differential count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
1.02×10-05
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head bobbing
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-2
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0266
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Sample clotted
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.880
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean/Body weight
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.518
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean/Body weight
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.610
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of ribs right
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of ribs right
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - ear
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body weight
|
HET
|
4f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body weight
|
HET
|
6f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Jump response
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Snout size
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Distance travelled - total
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.767
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel A
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 24kHz-evoked ABR Threshold
|
HET
|
9f:3m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0390
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0561
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - size
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0771
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery permanence time
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.661
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - length
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00614
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0557
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Others
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.809
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVAWd
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.237
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Aggression
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of center entries
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0316
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Pelvis
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Pelvis
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - shape
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength measurement mean
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0364
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Startle response
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel B
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Latency to fall
|
HET
|
30f:18m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 NKT cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.600
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - BN
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - shape
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean cell volume
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
1.67×10-05
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - back
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Femur
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Femur
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center permanence time
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.661
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 12kHz-evoked ABR Threshold
|
HET
|
9f:3m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0780
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength measurement
|
HET
|
30f:18m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - size
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena permanence
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-2
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.226
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Body weight
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Basophil cell count
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Density (excluding skull)
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0992
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Density (excluding skull)
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.208
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper lip morphology
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Red blood cell count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0250
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Locomotor activity
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.216
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.575
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Ambulatory activity (no. of beam cuts)
|
HET
|
132f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Ambulatory activity (no. of beam cuts)
|
HET
|
88f:132m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - tail
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - appearance
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / MZB
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.571
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration cue-1
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Hot plate latency
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI1
|
HET
|
9f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.663
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration context
|
HET
|
30f:18m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.698
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Mandibles
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Mandibles
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD24+ CD4 T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.524
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.282
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Neutrophil cell count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.367
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / T subset (Ly6C+)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Humerus
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Humerus
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - back paws
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Limb grasp
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - whole body
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel A
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of digits
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of digits
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - abdomen
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - head
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.151
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - presence
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery resting time
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.287
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of lumbar vertebrae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of lumbar vertebrae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Transitional B Cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.412
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - shape
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Ulna
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Ulna
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - head
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ T-Regs
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0761
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - number
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
3.93×10-05
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - length
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight after experiment
|
HET
|
4f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight after experiment
|
HET
|
6f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Monocyte cell count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.789
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of rears - total
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0167
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Unexpected behaviors
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Teeth
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Teeth
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-3
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0555
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - Global
|
HET
|
9f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0440
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of ribs left
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of ribs left
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Distance travelled
|
HET
|
40f:24m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - size
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - front paws
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Latency to fall mean
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.336
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Area
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00132
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Area
|
HET
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.520
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Weight / Body weight
|
HET
|
10f:7m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.803
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - head
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
10f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00696
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DP T cells
|
HET
|
6f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVIDs
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.982
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Cue freezing total
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.713
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Cellularity
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - shape
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - size
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.702
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Large Unstained Cell (LUC) differential count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.720
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total bilirubin
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0868
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.374
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total activity (no. of fine movement + no. of beam cuts)
|
HET
|
132f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total activity (no. of fine movement + no. of beam cuts)
|
HET
|
88f:132m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - position
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fusion of ribs
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fusion of ribs
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Flinch
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3_S
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.986
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / BMC/Body weight
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.302
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / BMC/Body weight
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.359
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower lip morphology
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - front paws
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Basophil differential count
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - abdomen
|
HET
|
10f:6m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Body weight
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ CD4 T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.839
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center resting time
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.144
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2_S
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.547
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Joints
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Joints
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration post-us
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Passive rotation
|
HET
|
30f:18m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement
|
HET
|
30f:18m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Skull shape
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Skull shape
|
HET
|
5f:m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Echo / Fractional Shortening
|
HET
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.891
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - number
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Gait
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / pDCs
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.375
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
88f:132m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
71f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Ears
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - number
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.949
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - presence
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI4
|
HET
|
9f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.135
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Tibia length
|
HET
|
4f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.214
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Tibia length
|
HET
|
5f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.423
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean mass
|
HET
|
6f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.507
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean mass
|
HET
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.986
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4_S
|
HET
|
9f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena average speed
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.129
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-1
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.181
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of pelvic vertebrae
|
HET
|
4f:5m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of pelvic vertebrae
|
HET
|
5f:m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.688
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / T cells (panel A)
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.987
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.658
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B Cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.999
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / gd T cells
|
HET
|
6f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.948
|
Successful |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - tail
|
HET
|
10f:6m
|
|
|
NotProcessed |
Gatad2btm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / White blood cell count
|
HET
|
10f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.400
|
Successful |